CELATOR PHARMACEUTICALS INC's ticker is CPXX and the CUSIP is 15089R102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $1,373,000 | – | 45,500 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 2,232,272 | $67,370,000 | 76.00% |
Avoro Capital Advisors LLC | 1,124,666 | $33,942,000 | 7.54% |
FIRST NEW YORK SECURITIES LLC /NY | 252,691 | $7,626,214,000 | 4.69% |
GLAZER CAPITAL, LLC | 965,785 | $29,147,000 | 3.76% |
HARVEST MANAGEMENT LLC | 150,000 | $4,527,000 | 3.42% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 290,000 | $8,752,000 | 3.11% |
Sandell Asset Management Corp. | 448,293 | $13,529,000 | 3.00% |
OMNI PARTNERS LLP | 7,293,750 | $7,294,000 | 2.71% |
First Trust Capital Management L.P. | 240,598 | $7,261,248,000 | 2.67% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 649,249 | $19,594,000 | 2.55% |